Inspired by NASA technology, Georgia Tech alumni launched Deleon—a startup using biochemical data to advance preventive health, backed by CREATE-X.
Georgia Tech’s Fall 2025 I2P Showcase will feature over 60 student prototypes tackling real-world challenges.
Two years into a $49.5 million cancer-mapping project, researchers are opening the door to new kinds of tests that could alert doctors to multiple kinds of cancer when they’re most treatable.
Born with a congenital limb disorder, Wallace wants to use his own experience to develop new prosthetics.
Georgia Tech and Vanderbilt researchers have built the first lung-on-a-chip with a working immune system, a breakthrough with the potential to reshape how we study disease, move beyond animal testing, and administer lifesaving therapies.
Nexus is Georgia Tech’s next-generation supercomputer, replacing the HIVE.
Schmidt Sciences announces next cohort of early-to mid- career scientists to each receive up to $2.5 million to pursue novel research
Record-breaking numbers from the Office of Commercialization drive meaningful inventions, IP, and industry partnerships.
Engineers use sodium bicarb to “self-pressurize” a pill able to deliver drugs that usually require injection directly to the small intestine.
Georgia Tech and Emory University are advancing Atlanta’s position as a top U.S. tech hub by relocating seven pioneering biomedical research labs to Science Square, a premier life sciences district driving innovation, talent, and economic growth.